Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 154th in Top Companies
- 22nd in Health
- 20th in Pharma
By Employees
(400)- 414th in Top Companies
- 65th in Health
- 42nd in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 8:59am Pub group Mitchells & Butlers profit rises on food and drink sales
- 8:09am Kerry co-op to raise €90m from sale of Kerry Group shares
- 7:28am Prolonged unseasonal weather pushes Origin Enterprises sales down
- 7:02am Alibaba to raise up to $12.9 bn in Hong Kong share sale
- 6:51am Aston Martin launches €170,000 SUV, hopeful of a turnaround